(May 18, 2020 / Israel21c) An immune system run amok may be responsible for some COVID-19 patients faring worse than others, suggests a new international study led by immunology researchers at Israel’s Weizmann Institute of Science.
In the study, published in the journal Cell on May 7 under the title, “Host-viral infection maps reveal signatures of severe COVID-19 patients,” researchers in the lab of professor Ido Amit introduce Viral-Track, a computational method they have validated to systematically detect viruses from multiple models of infection. They applied Viral-Track to lung cell samples from three mild and six severe COVID-19 cases to study how the SARS-CoV-2 virus modifies the lung cellular landscape.
They saw “a dramatic impact of the virus on the immune system of severe patients compared to mild cases,” report the authors, including researchers from the Zheng Lab at Shenzhen Third People’s Hospital in China and from Institut Pasteur in Paris.
In the lungs of patients severely affected by COVID-19, helpful alveolar macrophage immune cells appear to be replaced by a storm of harmful myeloid immune cells that intensify the impact of the virus.
Coauthor Amir Giladi said this immune system malfunction “represents the real mystery of coronavirus.”
“Applying Viral-Track to larger clinical cohorts could provide critical mechanistic understanding of SARS-CoV-2 interactions with its human host and devise new treatment strategies for severe patients,” Amit’s lab tweeted.
This could take the form of a drug to maintain the integrity of the helpful immune cells in the lung.
This article was first published by Israel21c.
Support Jewish Journalism
with 2020 Vision
One of the most intriguing stories of the sudden Coronavirus crisis is the role of the internet. With individuals forced into home quarantine, most are turning further online for information, education and social interaction.
JNS's influence and readership are growing exponentially, and our positioning sets us apart. Most Jewish media are advocating increasingly biased progressive political and social agendas. JNS is providing more and more readers with a welcome alternative and an ideological home.
During this crisis, JNS continues working overtime. We are being relied upon to tell the story of this crisis as it affects Israel and the global Jewish community, and explain the extraordinary political developments taking place in parallel.
Our ability to thrive in 2020 and beyond depends on the generosity of committed readers and supporters. Monthly donations in particular go a long way in helping us sustain our operations. We greatly appreciate any contributions you can make during these challenging times. We thank you for your ongoing support and wish you blessings for good health and peace of mind.